Y Intercept Hong Kong Ltd bought a new position in shares of ProAssurance Co. (NYSE:PRA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 34,644 shares of the insurance provider's stock, valued at approximately $551,000. Y Intercept Hong Kong Ltd owned about 0.07% of ProAssurance as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently modified their holdings of the company. Private Advisor Group LLC grew its holdings in ProAssurance by 12.8% in the 3rd quarter. Private Advisor Group LLC now owns 16,806 shares of the insurance provider's stock valued at $253,000 after buying an additional 1,905 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its stake in shares of ProAssurance by 402.1% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 68,435 shares of the insurance provider's stock valued at $1,029,000 after acquiring an additional 54,806 shares in the last quarter. FMR LLC increased its position in ProAssurance by 197.8% during the third quarter. FMR LLC now owns 12,063 shares of the insurance provider's stock worth $181,000 after acquiring an additional 8,012 shares during the period. BNP Paribas Financial Markets raised its stake in ProAssurance by 30.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 17,978 shares of the insurance provider's stock worth $270,000 after purchasing an additional 4,149 shares in the last quarter. Finally, Verition Fund Management LLC raised its stake in ProAssurance by 164.1% in the 3rd quarter. Verition Fund Management LLC now owns 36,589 shares of the insurance provider's stock worth $550,000 after purchasing an additional 22,737 shares in the last quarter. Institutional investors and hedge funds own 85.58% of the company's stock.
ProAssurance Trading Up 0.8 %
PRA stock traded up $0.12 during trading on Wednesday, hitting $15.71. The company had a trading volume of 257,403 shares, compared to its average volume of 251,220. The stock has a market cap of $803.57 million, a PE ratio of 18.93 and a beta of 0.27. The business has a 50-day moving average of $15.10 and a 200-day moving average of $15.14. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.35. ProAssurance Co. has a one year low of $10.76 and a one year high of $17.79.
ProAssurance (NYSE:PRA - Get Free Report) last issued its quarterly earnings results on Monday, February 24th. The insurance provider reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.19. ProAssurance had a return on equity of 2.65% and a net margin of 3.71%. The firm had revenue of $287.52 million during the quarter, compared to the consensus estimate of $274.56 million. Research analysts predict that ProAssurance Co. will post 0.8 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities analysts have weighed in on PRA shares. StockNews.com cut ProAssurance from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Truist Financial boosted their price target on ProAssurance from $14.00 to $18.00 and gave the company a "hold" rating in a research note on Tuesday, November 12th. Finally, Piper Sandler downgraded shares of ProAssurance from an "overweight" rating to a "neutral" rating and set a $18.00 price objective on the stock. in a research note on Monday, November 11th.
Check Out Our Latest Research Report on PRA
ProAssurance Company Profile
(
Free Report)
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Featured Articles
Before you consider ProAssurance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProAssurance wasn't on the list.
While ProAssurance currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
